Medical Condition

mild cognitive impairment mci

Total Trials

10

Recruiting Now

10

Trial Phases

Phase 2

ClinicalMetric tracks all active clinical trials for mild cognitive impairment mci sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — mild cognitive impairment mci Clinical Trials

How many clinical trials are currently recruiting for mild cognitive impairment mci?

ClinicalMetric currently tracks 10 actively recruiting clinical trials for mild cognitive impairment mci, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for mild cognitive impairment mci?

mild cognitive impairment mci research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a mild cognitive impairment mci clinical trial?

Eligibility criteria for mild cognitive impairment mci trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 2

Top Sponsors

McGill University 1 trial

University of Colorado, Denver 1 trial

Ohio University 1 trial

Casa di Cura IGEA 1 trial

The Hong Kong Polytechnic University 1 trial

Recruiting Clinical Trials

NCT03402919

Recruiting

Comprehensive Assessment of Neurodegeneration and Dementia

Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations

University of Colorado, Denver

View Trial →

NCT06828926

Recruiting

Project Gnosis: the Neurophysical and Psychosocial Health Outcomes of Tai Chi for Older Adults with Cognitive Concerns or Mild Cognitive Impairment

Italian Adaptation and Validation of Functional and Behavioural Scales for Subjective Cognitive Decline, Mild Cognitive Impairment and Mild Dementia.

Intermittent Theta-burst Stimulation for Mild Cognitive Impairment

The Hong Kong Polytechnic Univ...

View Trial →

NCT06601933 Phase 2

Recruiting

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial

Crownlands Observing Progression With Neurons Study

Effect of Inspiratory Muscle Training in Cognition

University of West Attica

View Trial →

NCT06783283

Recruiting

TACS to Engage Theta-Gamma Coupling and Enhance Working Memory in Patients With MCI (tACS-MCI)

Centre for Addiction and Menta...

View Trial →

NCT05014893

Recruiting

Neural Mechanisms of Cognitive Assessment and Rehabilitation for Cognitive Decline

National Research Center for R...

View Trial →

Related Conditions

subjective cognitive decline scd (3) dementia (1) subjective cognitive impairment (1) parkinson s disease pd (1) lewy body disease lbd (1) mixed dementia (1) frontotemporal dementia ftd (1) alzheimer disease ad (1) cognitively unimpaired (1) parkinsons disease pd (1) healthy adult (1) sarcopenia (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology